Literature DB >> 3816917

Effect of two different doses of nitrendipine on steady-state plasma digoxin level and systolic time intervals.

W Kirch, C Logemann, H Heidemann, S R Santos, E E Ohnhaus.   

Abstract

The effect of two different doses of nitrendipine on plasma digoxin levels, urinary recovery and systolic time intervals was investigated in 8 healthy volunteers. Following a loading dose, digoxin 0.25 mg b.d.p.o. was given alone for 2 weeks. Then 0.25 mg digoxin b.d. was administered for two 1-week periods combined with nitrendipine 10 mg or 20 mg once daily. The study was completed with another digoxin monotherapy phase lasting 7 days. Nitrendipine 20 mg daily led to a significant increase in plasma digoxin levels and in its area under the plasma concentration-time curve AUC (0-12) was 9.7 ng ml-1h when digoxin alone was given and 11.2 ng ml-1h on co-administration of the calcium antagonist. Urinary recovery and renal clearance of digoxin were slightly but not significantly increased by nitrendipine. Nitrendipine 10 mg once daily caused a small, insignificant tendency to elevate the plasma digoxin level. Nitrendipine co-administration (10 and 20 mg once daily) did not significantly alter systolic time intervals, as non-invasively measured haemodynamic parameters, compared to digoxin treatment alone. Thus, nitrendipine 20 mg daily caused a significant increase in plasma digoxin concentrations and in its AUC, which would rarely be of clinical relevance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3816917     DOI: 10.1007/bf00613512

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  [A study to the analysis of systolic time intervals (author's transl)].

Authors:  R Erbel; G G Belz
Journal:  Z Kardiol       Date:  1977-08

2.  Effects of nifedipine and diltiazem on plasma levels and renal excretion of beta-acetyldigoxin.

Authors:  J Kuhlmann
Journal:  Clin Pharmacol Ther       Date:  1985-02       Impact factor: 6.875

3.  Drug interactions with nitrendipine.

Authors:  W Kirch; H J Hutt; H Heidemann; K Rämsch; H D Janisch; E E Ohnhaus
Journal:  J Cardiovasc Pharmacol       Date:  1984       Impact factor: 3.105

4.  Nifedipine and beta-blockade as a cause of cardiac failure.

Authors:  R H Robson; M C Vishwanath
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-09

5.  Influence of nisoldipine on haemodynamic effects and plasma levels of digoxin.

Authors:  W Kirch; J Stenzel; P Dylewicz; H J Hutt; S R Santos; E E Ohnhaus
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

6.  Effect of nifedipine on serum digoxin concentration and renal digoxin clearance.

Authors:  J B Schwartz; P J Migliore
Journal:  Clin Pharmacol Ther       Date:  1984-07       Impact factor: 6.875

7.  Bioavailability and elimination of digitoxin in patients with hepatorenal insufficiency.

Authors:  W Kirch; E E Ohnhaus; P Dylewicz; J Pabst; L Storstein
Journal:  Am Heart J       Date:  1986-02       Impact factor: 4.749

8.  Quinidine-digoxin interaction: cardiac efficacy of elevated serum digoxin concentration.

Authors:  G G Belz; W Doering; P E Aust; M Heinz; J Matthews; B Schneider
Journal:  Clin Pharmacol Ther       Date:  1982-05       Impact factor: 6.875

9.  Effect of nifedipine on digoxin kinetics in healthy subjects.

Authors:  K E Pedersen; A Dorph-Pedersen; S Hvidt; N A Klitgaard; K Kjaer; F Nielsen-Kudsk
Journal:  Clin Pharmacol Ther       Date:  1982-11       Impact factor: 6.875

10.  Differential effects of systemic and intracoronary calcium channel blocking agents on global and regional left ventricular function in conscious dogs.

Authors:  R A Walsh; F R Badke; R A O'Rourke
Journal:  Am Heart J       Date:  1981-09       Impact factor: 4.749

View more
  7 in total

Review 1.  Pharmacokinetic interactions with calcium channel antagonists (Part II).

Authors:  K D Schlanz; S A Myre; M B Bottorff
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

2.  Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug-Drug Interactions and Co-medication Regimens.

Authors:  Daniel Moj; Nina Hanke; Hannah Britz; Sebastian Frechen; Tobias Kanacher; Thomas Wendl; Walter Emil Haefeli; Thorsten Lehr
Journal:  AAPS J       Date:  2016-11-07       Impact factor: 4.009

3.  Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. Ireland, 6-8 July, 1988. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

Review 4.  Calcium antagonists. Drug interactions of clinical significance.

Authors:  T Rosenthal; D Ezra
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

5.  Application of receiver operating characteristic analysis to refine the prediction of potential digoxin drug interactions.

Authors:  Harma Ellens; Shibing Deng; Joann Coleman; Joe Bentz; Mitchell E Taub; Isabelle Ragueneau-Majlessi; Sophie P Chung; Krisztina Herédi-Szabó; Sibylle Neuhoff; Johan Palm; Praveen Balimane; Lei Zhang; Masoud Jamei; Imad Hanna; Michael O'Connor; Dallas Bednarczyk; Malin Forsgard; Xiaoyan Chu; Christoph Funk; Ailan Guo; Kathleen M Hillgren; Libin Li; Anne Y Pak; Elke S Perloff; Ganesh Rajaraman; Laurent Salphati; Jan-Shiang Taur; Dietmar Weitz; Heleen M Wortelboer; Cindy Q Xia; Guangqing Xiao; Tetsuo Yamagata; Caroline A Lee
Journal:  Drug Metab Dispos       Date:  2013-04-25       Impact factor: 3.922

Review 6.  Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics.

Authors:  G G Belz; W Kirch; C H Kleinbloesem
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

7.  Heart failure drug digitoxin induces calcium uptake into cells by forming transmembrane calcium channels.

Authors:  Nelson Arispe; Juan Carlos Diaz; Olga Simakova; Harvey B Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-12       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.